Ameriprise
WX

Ameriprise’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Ameriprise’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,361
Closed -$836K – 4006
2015
Q3 		$836K Sell
19,361
-462,021
-96% -$19.5M ﹤0.01% 3052
2015
Q2 		$20.3M Sell
481,382
-654,550
-58% -$27.6M 0.01% 998
2015
Q1 		$44.1M Sell
1,135,932
-410,769
-27% -$15.8M 0.03% 578
2014
Q4 		$52.1M Buy
1,546,701
+264,041
+21% +$9.33M 0.03% 500
2014
Q3 		$44.9M Buy
1,282,660
+178,273
+16% +$6.11M 0.03% 549
2014
Q2 		$36.3M Buy
1,104,387
+160,166
+17% +$5.48M 0.02% 688
2014
Q1 		$34.8M Sell
944,221
-20,689
-2% -$759K 0.02% 695
2013
Q4 		$37M Sell
964,910
-89,284
-8% -$2.82M 0.02% 663
2013
Q3 		$28.9M Buy
1,054,194
+752,792
+250% +$17.8M 0.02% 796
2013
Q2 		$6.33M Buy
+301,402
New +$5.88M ﹤0.01% 1740

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Ameriprise's WX Position: Q4 2015 in Review

Ameriprise sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 19,361 shares — an estimated $836K sold.

Ameriprise first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $52.1M in Q4 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Ameriprise reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Ameriprise sold 19,361 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $836K.
  • Ameriprise first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Ameriprise's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $52.1M in Q4 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Ameriprise's 13F filing for Q4 2015, filed 11 Feb 2016.